Simple green production of silver nanoparticles facilitated by bacterial genomic DNA and their antibacterial activity
Source abstract
Abstract
Green synthesis of AgNPs has gained many research interests as a low cost and eco-friendly approach. This work reported on the use of bacterial genomic DNA as the alternative biopolymer for a green production of AgNPs under a neutral pH. Although both ssDNA and dsDNA could function as stabilizing agents during the synthesis process, the ssDNA, generated by pre-heating the dsDNA at 100 °C, was more efficient to produce AgNPs with higher yield as determined by the intensity of the surface plasmon resonance (SPR) peak of silver at 475 nm. The obtained AgNPs were spherical with the average diameter of 15.0 ± 7.6 nm, which their identity was confirmed by X-ray diffraction, high-resolution transmission electron microscopy, and selected area electron diffraction analyses. The synthesized AgNPs exhibited the potent antibacterial activity against both Escherichia coli and Staphylococcus aureus with the minimum bactericidal concentrations at 250 and 500 μg/ml, respectively, suggesting their potential antibacterial activity against both Gram-negative and Gram-positive bacteria.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoparticles: synthesis and applications · Advanced biosensing and bioanalysis techniques · Advanced Nanomaterials in Catalysis
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
School of Biology, Institute of Science, Suranaree University of Technology, Nakhon Ratchasima, Thailand
Funding
Suranaree University of Technology
References (31)
Show source-provided references
1. 10.3390/ijms1404788010.3390/ijms14047880 ↗
2. 10.1016/j.arabjc.2010.04.00810.1016/j.arabjc.2010.04.008 ↗
3. Iravani S · Res Pharm Sci · 2014 · 9 · 385
4. 10.3109/21691401.2014.93787010.3109/21691401.2014.937870 ↗
5. 10.1080/13102818.2015.113325510.1080/13102818.2015.1133255 ↗
6. 10.1080/21691401.2016.124179210.1080/21691401.2016.1241792 ↗
7. Mohammadi S · JECE · 2016 · 4 · 2023
8. 10.1016/j.jare.2015.02.00710.1016/j.jare.2015.02.007 ↗
9. 10.1016/j.colsurfa.2010.11.06010.1016/j.colsurfa.2010.11.060 ↗
10. 10.1007/s10570-012-9731-310.1007/s10570-012-9731-3 ↗
11. 10.1021/bm401414910.1021/bm4014149 ↗
12. 10.1080/21691401.2017.131326410.1080/21691401.2017.1313264 ↗
13. 10.1021/la950256w10.1021/la950256w ↗
14. 10.5923/j.nn.20120204.0210.5923/j.nn.20120204.02 ↗
15. 10.1038/pj.2013.5810.1038/pj.2013.58 ↗
16. Clinical Laboratory Standards Institute (CLSI). Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard—ninth edition, M07-A9. PA: Clinical Laboratory Standards Institute Wayne; 2012.
17. 10.1016/S2222-1808(14)60639-310.1016/S2222-1808(14)60639-3 ↗
18. 10.1016/j.ab.2015.06.03410.1016/j.ab.2015.06.034 ↗
19. 10.1016/j.jviromet.2016.08.01110.1016/j.jviromet.2016.08.011 ↗
20. 10.2147/IJN.S1686710.2147/IJN.S16867 ↗
21. 10.3390/nano501028410.3390/nano5010284 ↗
22. 10.22146/ijc.2122010.22146/ijc.21220 ↗
23. Yan J, SOH K, Cheng J. Antimicrobial yarn having nanosilver particles and methods for manufacturing the same. European Patent EP1490543B1. 2006.
24. 10.1016/j.colsurfb.2016.01.02710.1016/j.colsurfb.2016.01.027 ↗
25. 10.1021/ja056609n10.1021/ja056609n ↗
26. 10.1080/21691401.2016.119836510.1080/21691401.2016.1198365 ↗
27. 10.1186/1556-276X-6-43410.1186/1556-276X-6-434 ↗
28. 10.1016/j.nano.2015.11.01610.1016/j.nano.2015.11.016 ↗
29. 10.1016/j.nantod.2015.04.00210.1016/j.nantod.2015.04.002 ↗
30. 10.1016/j.jcis.2014.11.07410.1016/j.jcis.2014.11.074 ↗
31. 10.1016/j.cap.2016.05.02510.1016/j.cap.2016.05.025 ↗